Institute for Social Medicine, Epidemiology and Health Economics, Charité, Universitätsmedizin Berlin Center, Berlin, Germany,
Int J Public Health. 2014 Jun;59(3):509-17. doi: 10.1007/s00038-014-0547-9. Epub 2014 Mar 4.
OBJECTIVES: To measure the effects of an HIV-Care-Program, focusing on nutrition and lifestyle, which can be provided at scale to HIV-infected patients, on clinical and anthropometrical parameters, and health status. METHODS: A cluster-randomized trial, including 5 health facilities randomized to intervention n = 100 (HIV-Care-Program) or control n = 101 (Usual-Care). The HIV-Care-Program consisted of counseling lessons for 6 months, on: nutrition, hygiene, coping with stigma and discrimination, embedded in practical activities. Outcome variables were CD4 count after 6 months and time to antiretroviral therapy (ARV) initiation, using analysis of covariance and Kaplan-Meier method, respectively. RESULTS: After 6 months, CD4 count dropped by 46.3 cells (7.7%) (intervention) and 129 (23%) (control) (p = 0.003). Mean time to ARV; 5.9 months 95% CI (5.9, 6.0) (intervention); 4.9 months 95% CI (4.7, 5.2) (control) (p < 0.004). There was a partial correlation between CD4 count and initial viral load (r = -0.190, p = 0.017). CONCLUSIONS: The intervention provides a low-cost alternative improving health status, slowing down CD4 cell decline, delaying initiation of ARV and thus freeing local ARV capacities for patients in urgent need.
目的:评估一项针对 HIV 感染者的以营养和生活方式为重点的艾滋病关怀方案的效果,该方案可大规模提供给 HIV 感染者,以观察其对临床和人体测量参数以及健康状况的影响。
方法:这是一项整群随机试验,共纳入 5 个卫生机构,随机分为干预组(n=100,接受艾滋病关怀方案)和对照组(n=101,接受常规护理)。艾滋病关怀方案包括为期 6 个月的咨询课程,内容涵盖营养、卫生、应对污名和歧视,嵌入实践活动中。主要结局变量为 6 个月时的 CD4 计数,次要结局变量为开始抗逆转录病毒治疗(ART)的时间,分别采用协方差分析和 Kaplan-Meier 方法进行分析。
结果:6 个月后,CD4 计数下降了 46.3 个细胞(7.7%)(干预组)和 129 个细胞(23%)(对照组)(p=0.003)。开始 ART 的平均时间为 5.9 个月(95%CI:5.9,6.0)(干预组);4.9 个月(95%CI:4.7,5.2)(对照组)(p<0.004)。CD4 计数与初始病毒载量之间存在部分相关性(r=-0.190,p=0.017)。
结论:该干预措施提供了一种低成本的选择,可以改善健康状况,减缓 CD4 细胞下降速度,延迟开始抗逆转录病毒治疗,从而为急需的患者释放当地抗逆转录病毒治疗的能力。
Glob Health Action. 2015-8-17
Ann Intern Med. 2002-9-3
Clin Dev Immunol. 2012
J Acquir Immune Defic Syndr. 2011-4-15
Oxid Med Cell Longev. 2009